SYMGINE
Lactobacillus plantarum:
1. Sevda ER, et al. Anticandidal activities of lactic acid bacteria isolated from the vagina. Turk J Med Sci. 2019; 49:375-383
2. Cianci A, et al. Observational prospective study on Lactobacillus plantarum P 17630 in the prevention of vaginal infections, during and after systemic antibiotic therapy or in women with recurrent vaginal or genitourinary infections. J Obstet Gynaecol. 2018; 38:693-696
3. De Seta F, et al. Lactobacillus plantarum P17630 for preventing Candida vaginitis recurrence: a retrospective comparative study. Eur J Obstet Gynecol Reprod Biol. 2014; 182:136-9
4. Palacios S, et al. Is it possible to prevent recurrent vulvovaginitis? The role of Lactobacillus plantarum I1001 (CECT7504). Eur J Clin Microbiol Infect Dis. 2016; 35:1701-8
5. Vladareanu R, et al. New evidence on oral L. plantarum P17630 product in women with history of recurrent vulvovaginal candidiasis (RVVC): a randomized double-blind placebo-controlled study. Eur Rev Med Pharmacol Sci. 2018; 22: 262-267
Lactobacillus rhamnosus:
1. Chenoll E, et al. Selection of New Probiotics for Endometrial Health. Front Cell Infect Microbiol. 2019; 9:114.
2. Bertuccini L, et al. Effects of Lactobacillus rhamnosus and Lactobacillus acidophilus on bacterial vaginal pathogens. Int J Immunopathol Pharmacol. 2017; 30:163-167
3. Palma E, et al. Long-term Lactobacillus rhamnosus BMX 54 application to restore a balanced vaginal ecosystem: a promising solution against HPV-infection. BMC Infect Dis. 2018; 18:13
4. Reid G, et al. Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women. FEMS Immunol Med Microbiol. 2003; 35:131-4
Bifidobacterium animalis subsp. lactis:
1. Freitas AC & Hill JE. Quantification, isolation and characterization of Bifidobacterium from the vaginal microbiomes of reproductive aged women. Anaerobe 2017; 47:145-156
2. Freitas AC & Hill JE. Bifidobacteria isolated from vaginal and gut microbiomes are indistinguishable by comparative genomics. PLoS One 2018; 13: e0196290
3. Li SC, Hsu WF, et al. Combination of Lactobacillus acidophilus and Bifidobacterium animalis subsp. lactis Shows a Stronger Anti-Inflammatory Effect than Individual Strains in HT-29 Cells. Nutrients. 2019; 11:969
4. Sichetti M, et al. Anti-inflammatory effect of multistrain probiotic formulation (L. rhamnosus, B. lactis, and B. longum). Nutrition. 2018; 53:95-102.
5. Miller LE, et al. The Effect of Bifidobacterium animalis ssp. lactis HN019 on Cellular Immune Function in Healthy Elderly Subjects: Systematic Review and Meta-Analysis. Nutrients. 2017; 9:19
6. Paineau D, et al. Effects of seven potential probiotic strains on specific immune responses in healthy adults: a double-blind, randomized, controlled trial. FEMS Immunol Med Microbiol. 2008; 53:107-13
7. Gargari G, et al. Impact of a Multistrain Probiotic Formulation with High Bifidobacterial Content on the Fecal Bacterial Community and Short-Chain Fatty Acid Levels of Healthy Adults. Microorganisms. 2020; 8:492
L’associazione di L. plantarum, L. rhamnosus, B. animalis subsp. lactis:
2. Mezzasalma V, et al. Orally administered multispecies probiotic formulations to prevent uro-genital infections: a randomized placebo-controlled pilot study. Arch Gynecol Obstet. 2017; 295:163-172
3. Murina F & Vicariotto F. Evaluation of an Orally Administered Multistrain Probiotic Supplement in Reducing Recurrences Rate of Bacterial Vaginosis: A Clinical and Microbiological Study. Adv Infect Dis 2019; 9: 151-161
